Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
Tomida, Akimasa, Yagyu, Shigeki, Nakamura, Kayoko, Kubo, Hiroshi, Yamashima, Kumiko, Nakazawa, Yozo, Hosoi, Hajime, Iehara, Tomoko
Published in Cancer science (01.10.2021)
Published in Cancer science (01.10.2021)
Get full text
Journal Article
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
Kubo, Hiroshi, Yagyu, Shigeki, Nakamura, Kayoko, Yamashima, Kumiko, Tomida, Akimasa, Kikuchi, Ken, Iehara, Tomoko, Nakazawa, Yozo, Hosoi, Hajime
Published in Molecular therapy. Oncolytics (26.03.2021)
Published in Molecular therapy. Oncolytics (26.03.2021)
Get full text
Journal Article
A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cells
Yagyu, Shigeki, Mochizuki, Hidemi, Yamashima, Kumiko, Kubo, Hiroshi, Saito, Shoji, Tanaka, Miyuki, Sakamoto, Kengo, Shimoi, Akihito, Nakazawa, Yozo
Published in Clinical & translational immunology (2021)
Published in Clinical & translational immunology (2021)
Get full text
Journal Article